bioRxivZoology
Unprecedented incidence of Trypanosoma cruzi infections in a cohort of dogs directly detected through longitudinal tracking at multi-dog kennels, Texas, USA
R. E. Busselman, A. C. Meyers, I. B. Zecca, L. D. Auckland, A. H. Castro, R. E. Dowd, R. Curtis-Robles, C. L. Hodo, A. B. Saunders, S. A. Hamer
Abstract
Canine Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is increasingly recognized as a health concern for dogs in the USA, and infected dogs may signal geographic regions of risk for human disease. Dogs living in multi-dog kennel environments where triatomine vectors are endemic may be at high risk for infection. We monitored a cohort of 64 T. cruzi-infected and uninfected dogs from across 10 kennels in Texas, USA, to characterize changes in infection status over time. We used robust diagnostic criteria in which reactivity on multiple independent platforms was required to be considered positive. Among the 30 dogs enrolled as serologically- and/or PCR-positive, all but one dog showed sustained positive T. cruzi diagnostic results over time. Among the 34 dogs enrolled as serologically- and PCR-negative, 10 new T. cruzi infections were recorded over a 12-month period. The resulting incidence rate was 30.7 T. cruzi infections per 100 dogs per year. This study highlights the risk of T. cruzi infection to dogs in kennel environments, despite multiple vector control methods employed by kennel owners. To protect both dog and human health, there is an urgent need to develop more integrated vector control methods as well as prophylactic and curative antiparasitic treatment options for T. cruzi infection in dogs.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressure
J. Bustamante, A. Padilla, … R. L. Tarleton·bioRxiv·Jul 25, 2022
- Evaluation of a novel Tc-24 recombinant antigen ELISA for serologic testing for Trypanosoma cruzi in dogs
R. Mejia, G. G. Verocai, … S. A. Hamer·bioRxiv·Feb 12, 2024
- Randomized field trial of a therapeutic vaccine against Trypanosoma cruzi natural infection in dogs and correlates for efficacy
Jorge Andrés Calderón-Quintal, Christian Florian Teh-Poot, … Julio Vladimir Cruz-Chan·npj VaccinesPeer-reviewed·Dec 18, 2025
- Field Evidence of Trypanosoma cruzi Infection, Diverse Host Use and Invasion of Human Dwellings by the Chagas Disease Vector in Florida, USA
Norman L. Beatty, Chanakya R. Bhosale, … Samantha M. Wisely·PLoS neglected tropical diseasesPeer-reviewed·Jul 7, 2025
- Validation of a multiplex microsphere immunoassay for detection of Trypanosoma cruzi antibodies in dogs
C. A. Rodriguez, R. E. Busselman, … S. A. Hamer·bioRxiv·Mar 5, 2023
- High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA
A. M. Padilla, P. Yao, … R. L. Tarleton·bioRxiv·Jan 22, 2021